Systems biology of cancer: Moving toward the integrative study of the metabolic alterations in cancer cells

Frontiers in Physiology

Volumn 3 JAN, Issue , 2013, Pages

  Hernández Patiño, Claudia E ^a   Jaime Muñoz, Gustavo ^b   Resendis Antonio, Osbaldo ^c  

^a INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

Cancer metabolic phenotype; Computational modeling of metabolism; Constraint based modeling; Genome scale metabolic reconstruction; High throughput biology

Indexed keywords

CANCER CELL; CANCER CELL CULTURE; CELL METABOLISM; COMPUTER MODEL; GENETIC MODEL; GENOTYPE PHENOTYPE CORRELATION; HIGH THROUGHPUT SCREENING; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL MODEL; METHODOLOGY; PHENOTYPE; PREDICTION; QUANTITATIVE ANALYSIS; REVIEW; SYSTEMS BIOLOGY;

EID: 84874562089     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00481     Document Type: Review

References (41)

1. Benedict, M. N., Gonnerman, M. C., Metcalf, W. W., and Price, N. D. (2012). Genome-scale metabolic reconstruction and hypothesis test- ing in the methanogenic archaeon Methanosarcina acetivorans C2A. J. Bacteriol. 194, 855-865.
2. Bishop, J.M.,andWeinberg, R.A. (ed.). (1996). Molecular Oncology. New York, NY: Scientific American, Inc.
3. Bottomly, D., Kyler, S. L., McWeeney, S. K., and Yochum, G. S. (2010). Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res. 38, 5735-5745.
4. Brahimi-Horn, M. C., Chiche, J., and Pouyssegur, J. (2007). Hypoxia and cancer. J. Mol. Med. (Berl.) 85, 1301-1307.
5. Braun, R. D., Lanzen, J. L., Snyder, S. A., and Dewhirst, M. W. (2001). Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am.J.Physiol.HeartCirc. Physiol. 280, H2533-H2544.
6. Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., et al. (2008). The M2 splice isoform of pyru- vate kinase is important for can- cer metabolism and tumour growth. Nature 452, 230-233.
7. Dang, C. V., and Semenza, G. L. (1999). Oncogenic alterations of metabolism. Trends Biochem. Sci. 24, 68-72.
8. Fan, T. W., Lane, A. N., Higashi, R. M., Farag, M.A., Gao, H., Bousamra, M., et al. (2009). Altered regulation of metabolic pathways in human lung cancer discerned by (13)C sta- ble isotope-resolved metabolomics (SIRM). Mol. Cancer 8:41. doi: 10.1186/1476-4598-8-41
9. Fantin, V. R., St-Pierre, J., and Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physi- ology, and tumor maintenance. Cancer Cell 9, 425-434.
10. Gatenby, R. A., and Gillies, R. J. (2004). Why do cancers have high aero- bic glycolysis? Nat. Rev. Cancer 4, 891-899.
11. Godinot, C., de Laplanche, E., Hervouet, E., and Simonnet, H. (2007). Actuality of Warburg's views in our understanding of renal cancer metabolism. J. Bioenerg. Biomembr. 39, 235-241.
12. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
13. Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A.N., Dhanak, D., et al. (2005). ATP cit- rate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311-321.
14. Hsu, P. P., and Sabatini, D. M. (2008). Cancer cell metabolism: Warburg and beyond. Cell 134, 703-707.
15. Huarte, M., and Rinn, J. L. (2010). Large non-coding RNAs: missing links in cancer? Hum. Mol. Genet. 19, R152-R161.
16. Jones, R. G., and Thompson, C. B. (2009). Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 23, 537-548.
17. Kim, J., and Reed, J. L. (2012). RELATCH: relative optimal- ity in metabolic networks explains robust metabolic and regulatory responses to perturba- tions. Genome Biol 13:R78. doi: 10.1186/gb-2012-13-9-r78
18. King, A., Selak, M. A., and Gottlieb, E. (2006). Succinate dehydro- genase and fumarate hydratase: linking mitochondrial dysfunc- tion and cancer. Oncogene 25, 4675-4682.
19. Krieg, R. C., Knuechel, R., Schiffmann, E., Liotta, L. A., Petricoin, E. F. 3rd, and Herrmann, P. C. (2004). Mitochondrial proteome: cancer- altered metabolism associated with cytochrome c oxidase sub- unit level variation. Proteomics 4, 2789-2795.
20. Martinez, V. S., Dietmair, S., Quek, L. E., Hodson, M. P., Gray, P., and Nielsen, L. K. (2012). Flux balance analysis of CHO cells before and after a metabolic switch from lactate production to con- sumption. Biotechnol. Bioeng. doi: 10.1002/bit.24728. [Epub ahead of print].
21. McFate, T., Mohyeldin, A., Lu, H., Thakar, J., Henriques, J., Halim, N. D., et al. (2008). Pyruvate dehy- drogenase complex activity controls metabolic and malignant pheno- type in cancer cells. J. Biol. Chem. 283, 22700-22708.
22. Orth, J. D., Thiele, I., and Palsson, B. O. (2010). What is flux balance analy- sis? Nat. Biotechnol. 28, 245-248.
23. Paglia, G., Palsson, B. O., and Sigurjonsson, O. E. (2012). Systems biology of stored blood cells: can it help to extend the expiration date? J. Proteomics 76, 163-167.
24. Pardelha, F., Albuquerque, M. G., Reis, M. A., Dias, J. M., and Oliveira, R. (2012). Flux balance analysis of mixed microbial cultures: applica- tion to the production of poly- hydroxyalkanoates from complex mixtures of volatile fatty acids. J. Biotechnol. 162, 336-345.
25. Price, N. D., Reed, J. L., and Palsson, B. O. (2004). Genome-scale models of microbial cells: eval- uating the consequences of constraints. Nat. Rev. Microbiol. 2, 886-897.
26. Resendis-Antonio, O., Checa, A., and Encarnacion, S. (2010). Modeling core metabolism in cancer cells: surveying the topol- ogy underlying the Warburg effect. PLoS ONE 5:e12383. doi: 10.1371/journal.pone.0012383
27. Resendis-Antonio, O., Hernandez, M., Mora, Y., and Encarnacion, S. (2012). Functional modules, structural topology, and optimal activity in metabolic networks. PLoS Comput. Biol. 8:e1002720. doi: 10.1371/journal.pcbi.1002720
28. Resendis-Antonio, O., Hernandez, M., Salazar, E., Contreras, S., Batallar, G. M., Mora, Y., et al. (2011). Systems biology of bacterial nitrogen fix- ation: high-throughput technology and its integrative description with constraint-based modeling. BMC Syst. Biol. 5:120. doi: 10.1186/1752-0509-5-120
29. Resendis-Antonio, O., Reed, J. L., Encarnacion, S., Collado-Vides, J., and Palsson, B. O. (2007). Metabolic reconstruction and modeling of nitrogen fixation in Rhizobium etli. PLoS Comput. Biol. 3:e192. doi: 10.1371/journal.pcbi.0030192
30. Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B.K.,andGillies, R. J. (2005). Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 7, 324-330.
31. Schellenberger, J., Que, R., Fleming, R. M., Thiele, I., Orth, J. D., Feist, A. M., et al. (2011). Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc. 6, 1290-1307.
32. Shaw, R. J. (2006). Glucose metabolism and cancer. Curr. Opin. Cell Biol. 18, 598-608.
33. Sreekumar, A., Poisson, L. M., Rajendiran, T.M., Khan, A.P., Cao, Q., Yu, J., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914.
34. Thiery, J. P. (2002). Epithelial- mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
35. Tilghman, R. W., Blais, E. M., Cowan, C. R., Sherman, N. E., Grigera, P. R., Jeffery, E. D., et al. (2012). Matrix rigidity regulates cancer cell growth by modulating cel- lular metabolism and protein synthesis. PLoS ONE 7:e37231. doi: 10.1371/journal.pone.0037231
36. Varma, A., and Palsson, B. (1994). Stoichiometric flux balance mod- els quantitatively predict growth and metabolic byproduct secre- tion in wild-type Escherichia coli W(3110). Appl. Environ. Microbiol. 60, 3724-3731.
37. Venables, J. P., Klinck, R., Koh, C., Gervais-Bird, J., Bramard, A., Inkel, L., et al. (2009). Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16, 670-676.
38. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314.
39. Ward, P. S., and Thompson, C. B. (2012). Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21, 297-308.
40. Weinhouse, S. (1976). The Warburg hypothesis fifty years later. Z Krebsforsch. Klin. Onkol. Cancer Res. Clin. Oncol. 87, 115-126.
41. Xu, R. H., Pelicano, H., Zhou, Y., Carew, J.S., Feng, L., Bhalla, K.N., et al. (2005). Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65, 613-621.